Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and angiotensin ii

1-(carboxymethylthio)tetradecane has been researched along with angiotensin ii in 2 studies

Compound Research Comparison

Studies
(1-(carboxymethylthio)tetradecane)
Trials
(1-(carboxymethylthio)tetradecane)
Recent Studies (post-2010)
(1-(carboxymethylthio)tetradecane)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
14353238,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomy1-(carboxymethylthio)tetradecane (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berge, RK; Gudbrandsen, OA; Hultstrøm, M; Iversen, BM; Leh, S; Monica Bivol, L; Vågnes, Ø1
Berge, RK; Bivol, LM; Gudbrandsen, OA; Hultström, M; Iversen, BM1

Other Studies

2 other study(ies) available for 1-(carboxymethylthio)tetradecane and angiotensin ii

ArticleYear
Prevention of hypertension and organ damage in 2-kidney, 1-clip rats by tetradecylthioacetic acid.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:3

    Topics: Albuminuria; Angiotensin II; Animals; Blood Vessels; Dinoprost; Fatty Acids; Hypertension, Renovascular; Kidney; Liver; Male; Oleic Acid; Proteinuria; Rats; Rats, Wistar; Renin; RNA, Messenger; Sulfides; Vasoconstrictor Agents

2006
Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:6

    Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Constriction; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Down-Regulation; Hypertension, Renovascular; Infusions, Subcutaneous; Injections, Intra-Arterial; Kidney Cortex; Male; Membrane Proteins; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Wistar; Renal Artery; Renal Circulation; Sulfides; Time Factors

2008